Loading
Total declarations
Company
▲ Purchases (8 ops.)
▼ Sales (0 ops.)
Latest filing published 27 Apr 2026 for Day One Biopharmaceuticals, Inc., €237.9M.
Filing timeline
BuySaleAI Day1 LLC
Insider track record
Disclosed buys
8
Disclosed sells
0
Signal history
Closed purchases
Market purchases
4
Positive at T+90
50%
Median T+90
-11.0%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -30.1%Entry US$17.78 · Close at T+365 US$12.43
- +53.1%Entry US$14.01 · Close at T+365 US$21.45
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
AI Day1 LLC: trading record in brief
AI Day1 LLC is a declared insider of Day One Biopharmaceuticals, Inc., with filings sourced from SEC (Form 4). Between 18 January 2022 and 23 April 2026, the trades on record add up to 9 filings.
Purchases make up the whole of the open-market record (8 purchases, €41.9M). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The median purchase comes to €2.4M. None of the 8 purchases we analysed coincided with buying by another insider of the same company within 30 days.
On 27 April 2026 came the latest disclosure, a transaction for €237.9M in Day One Biopharmaceuticals, Inc. The last purchase on record was published on 20 October 2023, which is 1,102 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to AI Day1 LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
12,929,322 shares@ US$21.5028.35% mcap86.7% of flowCommon StockSEC:0001193125-26-182440:0
979,667 shares@ US$10.20763.5% of flowCommon StockSEC:0001209191-23-053235:0
Canonical exit: 16 Jan 2024 (T+90)
769,230 shares@ US$13.003.4% of flowCommon StockSEC:0001209191-23-036242:0
Canonical exit: 7 Sept 2023 (T+90)
1,200,000 shares@ US$15.001.78% mcap6.2% of flowCommon StockSEC:0001209191-22-038431:0
Canonical exit: 15 Sept 2022 (T+90)
43,429 shares@ US$14.26160.2% of flowCommon StockSEC:0001209191-22-004174:0
Canonical exit: 18 Apr 2022 (T+90)
5 of 5 declarations
